share_log

Cantor Fitzgerald Reiterates Overweight on Longboard Pharmaceuticals, Maintains $60 Price Target

Cantor Fitzgerald Reiterates Overweight on Longboard Pharmaceuticals, Maintains $60 Price Target

坎託·菲茨傑拉德重申增持Longboard Pharmicals,維持60美元的目標股價
Moomoo 24/7 ·  04/10 09:42

Cantor Fitzgerald analyst Josh Schimmer reiterates Longboard Pharmaceuticals (NASDAQ:LBPH) with a Overweight and maintains $60 price target.

坎託·菲茨傑拉德分析師喬什·希默重申朗博德製藥公司(納斯達克股票代碼:LBPH)增持,目標股價維持60美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論